10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $119,787 | -36.8% | 4,206 | +0.5% | 0.01% | -37.5% |
| Q2 2022 | $189,462 | -41.5% | 4,187 | -1.7% | 0.01% | -27.3% |
| Q1 2022 | $323,906 | -48.2% | 4,258 | +1.5% | 0.01% | -47.6% |
| Q4 2021 | $625,185 | +9.6% | 4,197 | +7.1% | 0.02% | 0.0% |
| Q3 2021 | $570,237 | -21.7% | 3,917 | +5.3% | 0.02% | -25.0% |
| Q2 2021 | $728,255 | +47.9% | 3,719 | +36.7% | 0.03% | +27.3% |
| Q1 2021 | $492,501 | -5.5% | 2,721 | -26.1% | 0.02% | -18.5% |
| Q4 2020 | $521,371 | +15981.8% | 3,682 | +14061.5% | 0.03% | – |
| Q3 2020 | $3,242 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |